Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit-Reference-Cited by-同舟云学术

Doxorubicin and doxorubicinol pharmacokinetics and tissue concentrations following bolus injection and continuous infusion of doxorubicin in the rabbit

Published:1993 Issue:1 Volume:32 Page:53-58
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Cusack Barry J.,Young Stephan P.,Driskell Joni,Olson Richard D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00685876.pdf

Reference36 articles.

1. Arcamone F (1976) Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4?-demethoxy-7,9-diepidaunorubicin, and other beta anomers. Cancer Treat Rep 60: 829

2. Bachur NR, Gee M (1971) Daunorubicin metabolism by rat tissue preparations. J Pharmacol Exp Ther 177: 567

3. Boucek RJ, Olson RD, Brenner DE, Ogunbunmi EM, Inui M, Fleischer S (1987) The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps. J Biol Chem 262: 15851

4. Brenner DE, Grosh WW, Wilkinson GER, Cooper J, Noone R, Stein R, Greco FA, Hande KR (1983) Clinical pharmacology of adriamycin (A) administered by continuous infusion: comparison to bolus administration. Proc Am Assoc Cancer Res 27: 134

5. Brenner DE, Noone R, Hande KR (1984) The rabbit as an in vivo model of anthracyline pharmacology: comparison of doxorubicin (dox) pharmacology in the rabbit (rab) and human (hum). Proc Am Assoc Cancer Res 28: 300

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin concentrations in bone tumour-relevant tissues after bolus and continuous infusion: a randomized porcine microdialysis study;Cancer Chemotherapy and Pharmacology;2024-02-08

2. Comparison of bolus administration and short-term infusion versus long-term infusion of doxorubicin in terms of cardiotoxicity and efficacy;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-14

3. Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairment;Blood Advances;2023-02-17

4. Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with ¹³¹I-Labeling and SPECT Imaging;Molecular Pharmaceutics;2023-01-20

5. Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling;Biomaterials;2022-07